stuurman fe
stuurman fe
Verified email at
Cited by
Cited by
Oral anticancer drugs: mechanisms of low bioavailability and strategies for improvement
FE Stuurman, B Nuijen, JH Beijnen, JHM Schellens
Clinical pharmacokinetics 52 (6), 399-414, 2013
Pulsatile drug delivery to ileo-colonic segments by structured incorporation of disintegrants in pH-responsive polymer coatings
RCA Schellekens, F Stellaard, D Mitrovic, FE Stuurman, JGW Kosterink, ...
Journal of controlled release 132 (2), 91-98, 2008
A novel dissolution method relevant to intestinal release behaviour and its application in the evaluation of modified release mesalazine products
RCA Schellekens, FE Stuurman, FHJ Van der Weert, JGW Kosterink, ...
European journal of pharmaceutical sciences 30 (1), 15-20, 2007
Effects of erythropoietin on cycling performance of well trained cyclists: a double-blind, randomised, placebo-controlled trial
JAAC Heuberger, JI Rotmans, P Gal, FE Stuurman, J van't Westende, ...
The Lancet Haematology 4 (8), e374-e386, 2017
Phase I study of oral CP-4126, a gemcitabine derivative, in patients with advanced solid tumors
FE Stuurman, EE Voest, A Awada, PO Witteveen, T Bergeland, PA Hals, ...
Investigational new drugs 31 (4), 959-966, 2013
Cerebrovascular events during nilotinib treatment
NG Jager, FE Stuurman, JW Baars, FL Opdam
Neth J Med 72 (2), 113-4, 2014
Phase I study of weekly oral docetaxel (ModraDoc001) plus ritonavir in patients with advanced solid tumors.
S Marchetti, F Stuurman, S Koolen, J Moes, J Hendrikx, B Thijssen, ...
Journal of Clinical Oncology 30 (15_suppl), 2550-2550, 2012
A dose-escalation study of bi-daily once weekly oral docetaxel either as ModraDoc001 or ModraDoc006 combined with ritonavir
VA de Weger, FE Stuurman, JJMA Hendrikx, JJ Moes, E Sawicki, ...
European Journal of Cancer 86, 217-225, 2017
A Phase 1 Comparative Pharmacokinetic and Cardiac Safety Study of Two Intravenous Formulations of CO‐101 in Patients With Advanced Solid Tumors
FE Stuurman, MP Lolkema, ADR Huitema, P Soetekouw, H Rosing, ...
The Journal of Clinical Pharmacology 53 (8), 878-883, 2013
Pharmacokinetic evaluation of three oral formulations of docetaxel boosted with ritonavir: two single-drug formulations vs. a fixed-dose combination tablet
JJ Moes, FE Stuurman, JJMA Hendrikx, S Marchetti, ADR Huitema, ...
Drug delivery and translational research 3 (3), 243-251, 2013
A novel somatostatin-dopamine chimera (BIM23B065) reduced GH secretion in a first-in-human clinical trial
WMI de Boon, MJ van Esdonk, FE Stuurman, NR Biermasz, L Pons, I Paty, ...
The Journal of Clinical Endocrinology & Metabolism 104 (3), 883-891, 2019
A Phase I Dose Escalation Study of Once-Weekly Oral Administration of Docetaxel as ModraDoc001 Capsule or ModraDoc006 Tablet in Combination with Ritonavir
VA de Weger, FE Stuurman, SLW Koolen, JJ Moes, JJMA Hendrikx, ...
Clinical Cancer Research 25 (18), 5466-5474, 2019
Repeatability and predictive value of lactate threshold concepts in endurance sports
JAAC Heuberger, P Gal, FE Stuurman, WAS de Muinck Keizer, ...
PloS one 13 (11), e0206846, 2018
426 Phase I study of oral CP-4126, a gemcitabine analog, in patients with advanced solid tumours
FE Stuurman, EE Voest, A Awada, JHM Schellens, PO Witteveen, ...
Ejc Supplements 7 (8), 135, 2010
Sensitivity and specificity of detection methods for erythropoietin doping in cyclists
JAAC Heuberger, P Van Eenoo, JI Rotmans, P Gal, FE Stuurman, TE Post, ...
Drug testing and analysis 11 (9), 1290-1301, 2019
The future of clinical trial design: the transition from hard endpoints to value-based endpoints
MD Kruizinga, FE Stuurman, GJ Groeneveld, AF Cohen
Concepts and Principles of Pharmacology: 100 Years of the Handbook of …, 2019
Recombinant human erythropoietin does not affect several microvascular parameters in well‐trained cyclists
WAJ Birkhoff, JAAC Heuberger, TE Post, P Gal, FE Stuurman, J Burggraaf, ...
Physiological Reports 6 (24), e13924, 2018
A phase I dose-escalation trial of bi-daily (BID) weekly oral docetaxel as ModraDoc006 in combination with ritonavir
VA de Weger, FE Stuurman, M Mergui-Roelvink, B Nuijen, ADR Huitema, ...
Annals of Oncology 27 (suppl_6), 399P, 2016
Patients with cancer on the ICU: Time for optimism
E de Jonge, DH van Raalte, M Diamant, SJ Rietjens, DW de Lange, ...
Neth J Med 72, 60-1, 2014
The Pharmacodynamic Effects of a Dopamine–Somatostatin Chimera Agonist on the Cardiovascular System
MJ van Esdonk, J Stevens, FE Stuurman, WMI de Boon, M Dehez, ...
Journal of cardiovascular pharmacology 74 (2), 128-136, 2019
The system can't perform the operation now. Try again later.
Articles 1–20